NASDAQ : ROIV
Roivant Sciences Ltd. — Financial statements
Healthcare · Biotechnology · United Kingdom
Last price 36.91 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 26.66B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Roivant Sciences Ltd. (ROIV) reported revenue of 7.53M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Revenue | 7.53M | 8.26M | 29.05M | 32.71M | 31.53M | 55.29M |
| Cost of Revenue | 731.42M | 682.20M | 545.52M | 431.61M | 457.10M | 469.10M |
| Gross Profit | -723.89M | -673.94M | -516.47M | -398.89M | -425.57M | -413.81M |
| Selling, General & Admin | 622.49M | 588.87M | 570.21M | 380.53M | 383.45M | 425.03M |
| Operating Expenses | 622.49M | 588.87M | 570.21M | 380.53M | 383.45M | 425.03M |
| Operating Income | -1.35B | -1.26B | -1.09B | -779.43M | -809.01M | -838.85M |
| Interest Expense | -7.04M | |||||
| Interest & Investment Income | 166.71M | 178.11M | 258.38M | 146.43M | 32.18M | 369.00K |
| Currency Exchange Gain (Loss) | 12.70M | 5.10M | ||||
| Other Non Operating Income (Expenses) | -44.98M | -48.79M | 5.04M | -60.40M | -18.87M | 73.06M |
| EBT Excluding Unusual Items | -1.21B | -1.13B | -823.27M | -693.40M | -795.70M | -772.46M |
| Gain (Loss) on Sale of Investments | 160.81M | 105.05M | 55.19M | -47.97M | -20.82M | 356.46M |
| Gain (Loss) on Sale of Assets | 11.03M | 11.03M | 113.50M | 5.38B | 29.28M | 5.04M |
| Asset Writedown | -17.10M | -17.10M | ||||
| Legal Settlements | 770.63M | 770.24M | ||||
| Other Unusual Items | -3.29M | -5.40M | -27.00M | -45.50M | -372.90M | |
| Pretax Income | -289.88M | -264.58M | -681.59M | 4.57B | -884.99M | -923.75M |
| Income Tax Expense | 124.72M | 133.33M | 48.17M | 21.50M | 4.08M | 369.00K |
| Earnings From Continuing Operations | -414.60M | -397.91M | -729.76M | 4.55B | -889.07M | -924.12M |
| Earnings From Discontinued Operations | 373.03M | -315.15M | -226.39M | |||
| Net Income to Company | -414.60M | -397.91M | -356.73M | 4.23B | -1.12B | -924.12M |
| Minority Interest in Earnings | 148.35M | 98.14M | 184.75M | 117.72M | 106.43M | 78.85M |
| Net Income | -266.25M | -299.77M | -171.98M | 4.35B | -1.01B | -845.26M |
| Net Income to Common | -266.25M | -299.77M | -171.98M | 4.35B | -1.01B | -845.26M |
| Shares Outstanding (Basic) | 703.99M | 693.86M | 725.40M | 783.25M | 712.79M | 669.75M |
| Shares Outstanding (Diluted) | 703.99M | 693.86M | 725.40M | 831.05M | 712.79M | 669.75M |
| EPS (Basic) | -0.38 | -0.43 | -0.24 | 5.55 | -1.42 | -1.26 |
| EPS (Diluted) | -0.49 | -0.54 | -0.24 | 5.23 | -1.42 | -1.26 |
| Free Cash Flow | -821.06M | -758.56M | -844.05M | -766.65M | -856.08M | -695.16M |
| Free Cash Flow Per Share | -1.17 | -1.09 | -1.16 | -0.92 | -1.20 | -1.04 |
| Operating Margin | -17,875.43% | -15,288.17% | -3,740.34% | -2,382.62% | -2,565.86% | -1,517.29% |
| Profit Margin | -3,534.96% | -3,629.19% | -591.96% | 13,294.18% | -3,200.22% | -1,528.89% |
| Free Cash Flow Margin | -10,901.00% | -9,183.51% | -2,905.21% | -2,343.56% | -2,715.14% | -1,257.40% |
| EBITDA | -1.34B | -1.26B | -1.07B | -757.39M | -790.16M | -832.92M |
| D&A For EBITDA | 2.85M | 3.35M | 14.07M | 22.04M | 18.86M | 5.93M |
| EBIT | -1.35B | -1.26B | -1.09B | -779.43M | -809.01M | -838.85M |
| Effective Tax Rate | 0.47% | |||||
| Revenue as Reported | 55.29M |
Balance sheet
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.25B | 1.42B | 2.72B | 6.49B | 1.68B | 2.06B |
| Short-Term Investments | 2.59B | 2.87B | 2.17B | |||
| Cash & Short-Term Investments | 3.84B | 4.29B | 4.89B | 6.49B | 1.68B | 2.06B |
| Accounts Receivable | 30.38M | 3.88M | ||||
| Other Receivables | 21.60M | 19.60M | 12.10M | 7.26M | 2.85M | |
| Receivables | 21.60M | 19.60M | 12.10M | 37.64M | 6.73M | |
| Inventory | 2.76M | |||||
| Prepaid Expenses | 60.83M | 53.37M | ||||
| Restricted Cash | 4.20M | 3.86M | 2.36M | 3.07M | 5.01M | 3.90M |
| Other Current Assets | 874.20M | 852.09M | 98.72M | 233.81M | 15.53M | 22.12M |
| Total Current Assets | 4.74B | 5.17B | 5.00B | 6.73B | 1.80B | 2.15B |
| Property, Plant & Equipment | 90.21M | 92.40M | 101.08M | 59.32M | 92.34M | 86.95M |
| Long-Term Investments | 444.62M | 407.99M | 302.94M | 247.75M | 304.32M | 325.83M |
| Other Intangible Assets | 144.88M | |||||
| Other Long-Term Assets | 29.59M | 40.92M | 32.86M | 183.58M | 49.48M | 25.82M |
| Total Assets | 5.31B | 5.71B | 5.44B | 7.22B | 2.39B | 2.59B |
| Accounts Payable | 25.08M | 18.00M | 23.69M | 14.03M | 37.83M | 34.58M |
| Accrued Expenses | 168.74M | 205.82M | 114.29M | 119.42M | 167.13M | 127.53M |
| Current Portion of Long-Term Debt | 40.72M | |||||
| Current Portion of Leases | 12.38M | 11.15M | 9.84M | 8.97M | 11.69M | 11.40M |
| Current Income Taxes Payable | 74.18M | 45.69M | 416.00K | 9.77M | 542.00K | 708.00K |
| Current Unearned Revenue | 4.17M | 12.44M | 10.15M | |||
| Other Current Liabilities | 3.21M | 583.00K | 1.17M | 110.41M | 2.09M | |
| Total Current Liabilities | 283.60M | 281.24M | 149.41M | 266.76M | 272.45M | 184.37M |
| Long-Term Debt | 375.51M | 210.03M | ||||
| Long-Term Leases | 94.77M | 96.29M | 90.33M | 45.02M | 53.48M | 62.47M |
| Other Long-Term Liabilities | 6.25M | 38.74M | 10.00M | 462.18M | 80.58M | 66.83M |
| Total Liabilities | 384.62M | 416.27M | 249.74M | 773.95M | 782.02M | 523.70M |
| Additional Paid-In Capital | 5.13B | 5.02B | 4.56B | 5.40B | 4.93B | 4.42B |
| Retained Earnings | -900.35M | -501.81M | 116.06M | 576.17M | -3.77B | -2.76B |
| Comprehensive Income & Other | 701.00K | 4.36M | 9.44M | -4.08M | -2.62M | -946.00K |
| Total Common Equity | 4.23B | 4.53B | 4.69B | 5.97B | 1.16B | 1.66B |
| Minority Interest | 690.60M | 765.04M | 499.59M | 479.95M | 449.82M | 404.49M |
| Shareholders' Equity | 4.92B | 5.29B | 5.19B | 6.45B | 1.61B | 2.06B |
| Total Liabilities & Equity | 5.31B | 5.71B | 5.44B | 7.22B | 2.39B | 2.59B |
| Total Debt | 107.15M | 107.44M | 100.17M | 53.99M | 481.40M | 283.89M |
| Net Cash (Debt) | 3.73B | 4.18B | 4.79B | 6.44B | 1.20B | 1.78B |
| Net Cash Per Share | 5.31 | 6.03 | 6.60 | 7.75 | 1.68 | 2.65 |
| Filing Date Shares Outstanding | 722.32M | 719.27M | 679.81M | 738.72M | 766.81M | 700.77M |
| Total Common Shares Outstanding | 722.67M | 720.35M | 695.94M | 806.68M | 760.14M | 694.98M |
| Working Capital | 4.46B | 4.89B | 4.85B | 6.47B | 1.53B | 1.96B |
| Book Value Per Share | 5.86 | 6.28 | 6.74 | 7.40 | 1.52 | 2.38 |
| Tangible Book Value | 4.23B | 4.53B | 4.69B | 5.97B | 1.01B | 1.66B |
| Tangible Book Value Per Share | 5.86 | 6.28 | 6.74 | 7.40 | 1.33 | 2.38 |
Cash flow statement
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -266.25M | -299.77M | -171.98M | 4.35B | -1.01B | -845.26M |
| Depreciation & Amortization | 2.85M | 3.35M | 14.07M | 22.04M | 18.86M | 5.93M |
| Loss (Gain) From Sale of Assets | -11.03M | -11.03M | -490.00M | -5.38B | -29.28M | -5.04M |
| Asset Writedown & Restructuring Costs | 15.59M | 15.59M | 87.75M | 78.22M | ||
| Loss (Gain) From Sale of Investments | -192.93M | -142.53M | -125.14M | 47.97M | 20.82M | -356.46M |
| Stock-Based Compensation | 347.33M | 346.17M | 289.03M | 199.63M | 217.78M | 564.96M |
| Other Operating Activities | -94.71M | -40.33M | -278.38M | -21.68M | -42.07M | -135.79M |
| Change in Accounts Payable | 22.27M | 3.42M | -18.17M | 22.68M | 4.36M | 15.40M |
| Change in Income Taxes | 77.86M | 85.05M | -10.05M | 9.93M | ||
| Change in Other Net Operating Assets | -717.46M | -710.26M | -48.83M | -13.58M | 1.99M | 316.00K |
| Operating Cash Flow | -816.47M | -750.35M | -839.45M | -765.27M | -843.39M | -677.73M |
| Capital Expenditures | -4.59M | -8.21M | -4.60M | -1.38M | -12.69M | -17.44M |
| Divestitures | -4.42M | -4.42M | 339.75M | 5.20B | -6.71M | -39.00K |
| Sale (Purchase) of Intangibles | -140.14M | |||||
| Investment in Securities | 696.17M | -667.19M | -2.10B | 320.17M | ||
| Other Investing Activities | -2.52M | -2.52M | 79.00K | 8.59M | 115.26M | 600.00K |
| Investing Cash Flow | 684.64M | -682.33M | -1.77B | 5.20B | -44.27M | 303.30M |
| Long-Term Debt Issued | 159.90M | 36.40M | ||||
| Long-Term Debt Repaid | -52.75M | -30.70M | -30.14M | -21.59M | ||
| Net Debt Issued (Repaid) | -52.75M | -30.70M | 129.75M | 14.81M | ||
| Issuance of Common Stock | 316.10M | 269.50M | 50.62M | 255.09M | 315.11M | 313.84M |
| Repurchase of Common Stock | -407.06M | -366.72M | -1.33B | -37.72M | -10.88M | |
| Other Financing Activities | 231.46M | 231.46M | 112.78M | 232.69M | 65.48M | -21.85M |
| Financing Cash Flow | 140.49M | 134.24M | -1.22B | 419.36M | 499.46M | 306.79M |
| Foreign Exchange Rate Adjustments | 3.27M | 3.77M | 747.00K | 616.00K | 6.28M | |
| Net Cash Flow | 11.93M | -1.29B | -3.82B | 4.86B | -381.92M | -67.64M |
| Free Cash Flow | -821.06M | -758.56M | -844.05M | -766.65M | -856.08M | -695.16M |
| Free Cash Flow Margin | -10,901.00% | -9,183.51% | -2,905.21% | -2,343.56% | -2,715.14% | -1,257.40% |
| Free Cash Flow Per Share | -1.17 | -1.09 | -1.16 | -0.92 | -1.20 | -1.04 |
| Levered Free Cash Flow | -1.12B | -1.08B | -375.20M | -344.21M | -410.41M | 36.92M |
| Unlevered Free Cash Flow | -1.12B | -1.08B | -375.20M | -344.21M | -410.41M | 41.32M |
| Cash Interest Paid | 5.96M | 10.27M | 5.30M | 5.54M | ||
| Cash Income Tax Paid | 48.37M | 48.37M | 61.91M | 12.35M | 5.13M | 916.00K |
| Change in Working Capital | -617.33M | -621.80M | -77.05M | 19.04M | 6.34M | 15.72M |
Ratios
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 25.92B | 19.82B | 7.20B | 8.49B | 5.60B | 3.42B |
| Enterprise Value | 22.19B | 16.11B | 2.50B | 2.82B | 5.02B | 1.89B |
| Last Close Price | 35.89 | 27.70 | 10.09 | 10.54 | 7.38 | 4.94 |
| PE Ratio | 1.95 | |||||
| PS Ratio | 3,441.87 | 2,400.11 | 247.81 | 259.64 | 177.52 | 61.84 |
| PB Ratio | 6.13 | 3.75 | 1.39 | 1.32 | 3.48 | 1.66 |
| P/TBV Ratio | 6.13 | 4.38 | 1.54 | 1.42 | 5.53 | 2.06 |
| EV/Sales Ratio | 2,946.00 | 1,950.22 | 86.05 | 86.33 | 159.25 | 34.11 |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.01 | 0.30 | 0.14 |
| Net Debt / Equity Ratio | -0.76 | -0.79 | -0.92 | -1.00 | -0.74 | -0.86 |
| Net Debt / EBITDA Ratio | 2.78 | 3.32 | 4.46 | 8.50 | 1.51 | 2.13 |
| Net Debt / FCF Ratio | 4.55 | 5.52 | 5.67 | 8.40 | 1.40 | 2.56 |
| Asset Turnover | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 |
| Quick Ratio | 13.62 | 15.33 | 32.79 | 24.35 | 6.29 | 11.21 |
| Current Ratio | 16.72 | 18.37 | 33.47 | 25.24 | 6.60 | 11.64 |
| Return on Equity (ROE) | -8.52% | -7.59% | -12.54% | 112.87% | -48.46% | -44.82% |
| Return on Assets (ROA) | -16.28% | -14.16% | -10.73% | -10.14% | -20.33% | -20.26% |
| Return on Invested Capital (ROIC) | -117.33% | -167.43% | -271.35% | -232.11% | -312.50% | |
| Return on Capital Employed (ROCE) | -26.80% | -23.30% | -20.60% | -11.20% | -38.20% | -34.90% |
| Earnings Yield | -1.36% | -1.51% | -2.39% | 51.20% | -18.03% | -24.72% |
| FCF Yield | -3.17% | -3.83% | -11.72% | -9.03% | -15.29% | -20.33% |
| Buyback Yield / Dilution | 1.06% | 4.35% | 12.71% | -16.59% | -6.43% | -6.30% |